Tradestie Institutional Equity Comparison Engine
MXCT vs DCTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus DCTH at 69.0x Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in CONSOLIDATION (26th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
MXCT N/M vs DCTH 69.0x Fwd P/E
Growth & Margin Winner
DCTH
Op Margin -85.5% vs 5.2% ยท YoY +48.7% vs +70.7%
Momentum & Technical Winner
DCTH
1Y -19.4% vs +120.8% ยท 52W Pos 63% vs 74%
Options & Structure Winner
DCTH
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (26th %ile IV)
MXCT
NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap
$132.2M
1M Return
-4.2%
1Y Return
-19.41%
Forward P/E
N/M
Unified AI Score
41.7 / 100
SELL
Tech 46.0
Fund 52.0
Flow 62.0
Mom 50.0
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$18.79
-2.34% 1D
Market Cap
$669.3M
1M Return
+27.39%
1Y Return
+120.8%
Forward P/E
69.0x
Unified AI Score
35.2 / 100
SELL
Tech 50.0
Fund 36.0
Flow 70.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MXCT -19.41%
DCTH +120.8%
Spread: +140.21 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MXCT Revenue | DCTH Revenue | MXCT Op. Margin | DCTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2015 | N/A | $0M | N/A | -870.6% | DCTH |
| FY2019 | $10M | N/A | -93.7% | N/A | MXCT |
| FY2020 | $20M | N/A | -71.6% | N/A | MXCT |
| FY2021 | $20M | $0M | -84.3% | -690.0% | MXCT |
| FY2022 | $30M | $0M | -95.2% | -1245.1% | MXCT |
| FY2023 | $20M | $0M | -247.7% | -1849.0% | MXCT |
| FY2024 | $20M | $40M | -230.5% | -33.4% | DCTH |
| FY2025 | $20M | $90M | -247.6% | 0.8% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MXCT | DCTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.2M | $669.3M | Larger Scale | DCTH |
| Trailing P/E Ratio Valuation | N/M | 120.2x | Lower Multiple | DCTH |
| Forward P/E Ratio Valuation | N/M | 69.0x | Lower Multiple | DCTH |
| Revenue Growth (YoY) Growth | +48.7% | +70.7% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | -85.5% | 5.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | -81.4% | 6.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | -16.9% | 5.4% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 63% ($1โ$2) | 74% ($8โ$23) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 96% Vol | 1.57ฮฒ ยท 130% Vol | Lower Realized Risk | MXCT |
| Unified Institutional Score Composite Signal | 41.7 / 100 (SELL) | 35.2 / 100 (SELL) | Higher Composite | MXCT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MXCT vs DCTH Buy Guide
MXCT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DCTH
CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
26th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MXCT nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.